Hostname: page-component-848d4c4894-4rdrl Total loading time: 0 Render date: 2024-06-29T00:25:38.386Z Has data issue: false hasContentIssue false

Treatment of schizophrenia using tablet and smartphone based applications (Polish Study)

Published online by Cambridge University Press:  23 March 2020

M. Krzystanek
Affiliation:
Medical University of Silesia, Department of Rehabilitation Psychiatry, Katowice, Poland
D. Krzeszowski
Affiliation:
Specialistic Outpatient Clinic, Kużaja 57Radzionków, Poland
K. Jagoda
Affiliation:
Specialistic Outpatient Clinic, Kużaja 57Radzionków, Poland
B. Radzio
Affiliation:
Specialistic Outpatient Clinic, Zuchów 3Wodzisław Śląski, Poland
K. Krysta*
Affiliation:
Medical University of Silesia, Department of Psychiatry and Psychotherapy, Katowice, Poland
*
* Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Relapses, deterioration of cognitive functioning, negative symptoms, neuroleptic resistance are the examples of many consequences of noncompliance in schizophrenia. In order to improve the compliance, schizophrenic patients treated in an outpatient department in a traditional way have been given an additional possibility of contacting their doctors with the use of a special application on a portable electronic device. Other functions of this application are possibilities of PANSS, Calgary and CGI measurements and cognitive trainings for the patients. This type of a remote contact with patients can be an effective tool in the work in an outpatient setting. The compliance was assessed using a telepsychiatric system, sending reminders: 1 hour before the planned dose to remind them that drug intake is approaching, and at the moment of intake to check if they took the drug. In general the compliance in the group of schizophrenic patients in remission is very low, however the telemedicine system improves the compliance in this group of patients, in which the compliance is the worst.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
S29
Copyright
Copyright © European Psychiatric Association 2016
Submit a response

Comments

No Comments have been published for this article.